How to Buy Hinge Health Stock
Hinge Health Inc
Hinge Health is a health information service company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker HNGE on the NYSE exchange.
Hinge Health stock last closed at $90.02, down 2.74% from the previous day, and has increased 61.67% in one year. It has overperformed other stocks in the Health Information Services industry by 0.96 percentage points. Hinge Health stock is currently +199.27% from its 52-week low of $30.08, and -5.81% from its 52-week high of $95.57.
As of Sep 1, 2026, there are 80.69M HNGE shares outstanding. The market capitalization of HNGE is $7.26B. In the last 24 hours, 1.73M HNGE shares were traded.
How to Buy Hinge Health Stock
Not sure how to invest in Hinge Health stock? Here's how.
- Figure out where to buy Hinge Health stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Hinge Health stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Choose your method of payment and add your details.
- Research Hinge Health stock: The Hinge Health ticker symbol is HNGE. Is Hinge Health stock a good investment? Should you buy shares of HNGE? How do HNGE's underlying business fundamentals look? Do top analysts think Hinge Health is a good buy? Why has HNGE's stock price moved recently? (Hint: Our stock market analysis website can help you decide if HNGE is a good stock to buy).
- Place your HNGE buy order: Decide if you will purchase HNGE shares at the current market price or use a limit order to purchase HNGE stock at a given price.
- Get key alerts regarding your HNGE investment: Create a watchlist to important notifications about your new investment in Hinge Health stock.
Step 1: Figure out where to buy Hinge Health stock
You need a brokerage account in order to access the NYSE market and buy HNGE shares.
Our favorite brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global markets: From Technology to Energy, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal info so you can buy HNGE stock today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to open a new brokerage account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have filled out your info on one of the best stock market apps, you need to deposit funds:
Watch the video below to see the process of transferring money into your investment account.
Step 4: Research Hinge Health stock
Once you have figured out the best place to buy Hinge Health stock, it's crucial to research their stock prior to buying, so you actually wrap your head around the risk and upside.
Hinge Health shares at a glance
HNGE Overview
WallStreetZen was designed to help part-time investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on HNGE's stock page.
How is HNGE stock valued?
Investors use many financial metrics, analyses, models, and charts to gauge HNGE's intrinsic value.
Using relative valuations methods:
- HNGE could be overvalued based on its P/E ratio of 29.32x, relative to Health Information Services industry P/E ratio of 11.85x
- HNGE may be overvalued based on its P/B ratio of 21.1x, relative to Health Information Services industry P/B ratio of 3.91x
- HNGE may be overvalued based on its PEG ratio of 2.56x
You can do more valuation research on HNGE's stock here.
HNGE Financial Health
Pros:
- HNGE earnings of $110.95M is not sufficient to cover its interest payments.
- HNGE's operating cash flow of $290.79M allows it to safely service it's debt of $5.89M.
- There are more short-term assets than long-term liabilities on the HNGE balance sheet.
- HNGE profit margin has gone up from -88.8% to 14.9% in the past year.
- There are more short-term assets than short-term liabilities on the HNGE balance sheet.
Cons:
- HNGE has a relatively high debt to equity ratio of 1.4.
Is it a good time to buy HNGE stock, according to analysts?
Out of 13 Wall Street analysts who track HNGE, the consensus analyst rating on HNGE is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Latest HNGE Analyst Recommendations
Saket Kalia, a top 2% analyst from Barclays maintains HNGE with a strong buy rating and raises their HNGE price target from $97.00 to $100.00, on Aug 5, 2026.
Barclays's Saket Kalia raised their price target on Hinge Health (NYSE: HNGE) by 3.1% from $97 to $100 on 2026/08/05. The analyst maintained their Strong Buy rating on the stock.
Hinge Health reported its Q2 2026 earnings.
Raising their price target, Kalia attributed the quarter's beat-and-raise results to improving yields and growth in competitive win rates.
Earnings Report
For Q2 2026, Hinge Health reported:
- EPS of $0.59, which met the Zacks Consensus Estimate but missed Q2 2025's $0.67.
- Revenue of $212.82M, which beat the Zacks Consensus Estimate by 6.14% and Q2 2025's $139.1M.
Management guided:
For Q3 2026:
- Revenue of $223M to $225M.
For FY 2026:
- Revenue of $856M to $860M (raised).
CEO Daniel Perez commented: “We delivered another strong quarter ahead of expectations, generating $213 million in revenue with 53% year-over-year growth, while more than tripling free cash flow from a year ago.
"This quarter’s outperformance was driven by continued high member conversion and reflects our ability to deliver a great experience, improve member outcomes and lower client costs.
“We also announced the acquisition of Cylinder Health today, marking our entry into gastrointestinal (GI) care.
"Combined with the strength of our core musculoskeletal care programs and the rapid adoption of our Migraine Care Program, our expansion into GI is another step toward our vision of building a durable, multi-condition platform to automate the delivery of care.
"Building on this momentum, we're raising our revenue and profitability expectations for the remainder of 2026, and are confident in our trajectory for 2027.”
Ryan MacDonald, a bottom 6% analyst from Needham maintains HNGE with a buy rating and raises their HNGE price target from $76.00 to $97.00, on Aug 5, 2026.
David Grossman, a top 17% analyst from Stifel Nicolaus maintains HNGE with a strong buy rating and raises their HNGE price target from $79.00 to $90.00, on Jul 27, 2026.
Richard Close, a bottom 3% analyst from Canaccord Genuity maintains HNGE with a strong buy rating and raises their HNGE price target from $76.00 to $100.00, on Jul 21, 2026.
Scott Schoenhaus, a bottom 2% analyst from KeyBanc maintains HNGE with a strong buy rating and raises their HNGE price target from $90.00 to $125.00, on Jul 13, 2026.
You can dive deeper into what analysts are saying on the Hinge Health stock forecast page.
Metrics for Advanced HNGE Traders
HNGE Performance Metrics
Last year, HNGE revenue was $720.06M. Over the last one years, HNGE's revenue has increased by 49.76% per year. This was faster than the Health Information Services industry average of 21.79%.
You can analyze HNGE's earnings and revenue performance here.
What are HNGE insiders up to?
Over the past 12 months, executives and large shareholders at HNGE have sold more shares than they have bought.
James Pursley, Pres of HNGE, was the latest HNGE insider to sell. They sold $42,401.00 worth of HNGE shares on Aug 21, 2026.
Learn more about who owns HNGE stock here.
Can I rely on HNGE as an income stream?
No, Hinge Health doesn't provide an income stream by paying out dividends.
What others are saying about HNGE
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your HNGE buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given price, place a limit order.
Hit the Open button and your broker will execute your order.
If you want more assistance buying stocks on eToro, watch the how to video below:
Step 6: Get key alerts regarding your HNGE investment
Now that you own some HNGE shares, you'll want to keep up with your company.
Put HNGE on a watchlist to get the latest updates about your HNGE stock.
HNGE Feed
How to Buy Stock in Hinge Health
To reiterate, here are the 6 steps to buy Hinge Health stock:
- Figure out where to buy Hinge Health stock
- Create your brokerage account
- Put funds into your brokerage account
- Research Hinge Health stock
- Place your HNGE buy order
- Get key alerts regarding your HNGE investment
If you are looking for a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to track your investment in Hinge Health, get started below.
Other Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.